Oncview


EGFR Exon 20 Insertion As A Therapeutic Target in Non-small Cell Lung Cancer

November 18th 2021

A leading expert in lung cancer provides insights on recent data and review updates in the treatment landscape for patients with non-small-cell lung cancer and exon 20 insertions.

Recent Updates in Treatment of Non-Metastatic Castration Resistant Prostate Cancer

November 16th 2021

Dr Aaron Berger discusses recent advances in treatment and management of patients with nonmetastatic castrate-resistant prostate cancer.

Immunotherapy Response Monitoring in Lung Cancer

October 18th 2021

Roy S. Herbst, MD, PhD, reviews currently available treatment options in immunotherapy in non-small-cell lung cancer and approaches to monitoring treatment response.

PARP Inhibitors in Prostate Cancer

October 15th 2021

Part 1: Oliver Sartor, MD, gives an overview of the use of PARP inhibitors to treat metastatic castration-resistant prostate cancer.

Part 2: Alicia Morgans, MD, MPH, discuses the importance of PARP inhibitors in the treatment of metastatic prostate cancer, as well as castration-resistant prostate cancer.

Immunotherapy Response Monitoring in Melanoma

October 12th 2021

John Kirkwood, MD, PhD, discusses the use of immunotherapy as a treatment option for melanoma, including ctDNA, and how to properly monitor responses.

Updates in Therapies of Relapse/Refractory Follicular Lymphoma

September 7th 2021

Connie Batlevi, MD, PhD, explains the treatment options for relapsed/refractory follicular lymphoma and discusses a recent drug approval.

Updates in Therapies of Relapsed and Refractory Follicular Lymphoma

July 6th 2021

Javier L. Munoz, MD, MS, FACP, explains the treatment options for relapsed/refractory follicular lymphoma and provides insight into a recent clinical trial.

NCCN Guideline Updates in HR+ Breast Cancer: Focus on Extended Adjuvant Therapy

June 28th 2021

Recommendations for utilizing genomic testing to aid in treatment decisions for early-stage HR+ breast cancer based on updates to the NCCN guidelines.

Management of Relapsed/Refractory Follicular Lymphoma

May 12th 2021

Sameh Gaballa, MD, reviews the treatment options for relapsed/refractory follicular lymphoma and future treatment options.

Updates in the Management of Extensive-Stage Small Cell Lung Cancer

May 10th 2021

Considerations for adding immunotherapy to the armamentarium for frontline treatment of extensive-stage small cell lung cancer.